In contrast, IBAG257 reactivity showed a decline of only borderline significance in both the 100 mg kg -1 benznidazole and the vehicle-treated subgroups ( Fig 3C ).
← all excerpts
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure.
1
—
—